ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Miami, FL, USA:

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Adult T-cell leukemia/lymphoma (ATLL) is a rare form of cancer found mostly among people from the Caribbean islands, Western Africa, Brazil,...

Active, not recruiting
Lymphoma
Adult T-Cell Leukemia/Lymphoma
Drug: CHEP
Drug: Brentuximab Vedotin

Phase 2

UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center

Hollywood, Florida, United States and 3 other locations

regimen, R-CHP, as a treatment for high-risk diffuse large B-cell lymphoma.The names of the treatment interventions involved in this study a...

Active, not recruiting
Lymphoma, Large B-Cell, Diffuse
Lymphoma
Drug: Cyclophosphamide
Drug: Prednisone

Phase 2

Jennifer Crombie, MD

Miami, Florida, United States and 2 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

Coral Gables FL, Florida, United States and 31 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Enrolling
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Miami Beach, Florida, United States and 71 other locations

The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
Relapsed B-Cell Non-Hodgkin Lymphoma
Drug: Loncastuximab Tesirine
Drug: Polatuzumab Vedotin

Phase 1

ADC Therapeutics

Miami, Florida, United States and 34 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Miami, Florida, United States and 215 other locations

RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led...

Enrolling
Hodgkin Lymphoma
Drug: Vinblastine
Drug: Dacarbazine

Phase 3

University College London (UCL)
University College London (UCL)

Miami, Florida, United States and 40 other locations

works, after autologous stem cell transplant as a maintenance therapy in patients with indolent or transformed indolent B-cell non-Hodgkins lymphoma...

Active, not recruiting
Indolent Lymphoma
Marginal Zone Lymphoma
Drug: Zydelig

Phase 2

University of Maryland Baltimore (UMB)
University of Maryland Baltimore (UMB)

Miami, Florida, United States and 2 other locations

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Enrolling
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Miami, Florida, United States and 56 other locations

The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and Tafasitamab in patients with mantle cell lymphoma...

Enrolling
Mantle Cell Lymphoma
Drug: Zanubrutinib
Drug: Tafasitamab

Phase 1, Phase 2

Alvaro Alencar, MD

Miami, Florida, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems